ICD-10-CM Billable Code

C83.18

Mantle cell lymphoma, lymph nodes of multiple sites

Clinical Classification Guidelines

Medical Intelligence & Overview

Mantle cell lymphoma (MCL) is a type of non-Hodgkin lymphoma that originates from B lymphocytes, a kind of white blood cell involved in immune responses. When this lymphoma affects lymph nodes in multiple parts of the body, it can indicate an advanced stage of the disease. The specific ICD-10 code C83.18 is used to categorize cases where mantle cell lymphoma involves lymph nodes across various sites, highlighting its widespread nature. Recognizing and understanding this condition helps in comprehending its impact on health and the importance of appropriate medical management.

Causes & Symptoms

Clinical Causes: Genetic mutations affecting B lymphocytes Changes in DNA that lead to uncontrolled cell growth Increased risk with age, particularly in individuals over 60 Possible familial links, although rare Exposure to certain chemicals or environmental factors—though definitive causes are unclear

Key Symptoms: Swollen lymph nodes in multiple regions such as the neck, armpits, or groin Unexplained weight loss Persistent fever Profuse night sweats Fatigue and weakness Abdominal discomfort or swelling Loss of appetite Frequent infections due to weakened immune function

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation and laboratory tests, including:

Treatment Protocols: Treatment approaches for mantle cell lymphoma with multiple lymph node involvement aim to control disease progression and alleviate symptoms. These may include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C83.18 a billable ICD-10 code?
Yes, C83.18 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C83.18?
Clinical documentation must specify the nature of Mantle cell lymphoma, lymph nodes of multiple sites and any associated comorbidities for accurate reporting.

Cite this Clinical Reference